Home
About
FAQ
History (14)
What you hear is what you get.
Ebola Virus Disease Simulation Case Series: Patient With Ebola Virus Disease in the Prodromal Phase of Illness (Scenario 1), the "Wet" Gastrointestinal Phase of Illness (Scenario 2), and the Late, Critically Ill Phase of Disease (Scenario 3).
Acyl-lipid desaturases and Vipp1 cooperate in cyanobacteria to produce novel omega-3 PUFA-containing glycolipids.
Uncompensated care provided by for-profit, not-for-profit, and government owned hospitals.
EPR spectroscopic and computational characterization of the hydroxyethylidene-thiamine pyrophosphate radical intermediate of pyruvate:ferredoxin oxidoreductase.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (12)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Steven R. Feldman MD, PhD
Wake Forest School of Medicine
Why?
Mark O. Lively PhD
Wake Forest School of Medicine
Why?
Colin E. Bishop PhD
Wake Forest School of Medicine
Why?
Anne E. Argenta MD
Wake Forest School of Medicine
Why?
Mark A. Hall JD
Wake Forest School of Medicine
Why?
Richard W. Lord MD
Wake Forest School of Medicine
Why?
Goldie S. Byrd PhD
Wake Forest School of Medicine
Why?
Barbara Nicklas PhD
Wake Forest School of Medicine
Why?
Michael P. Lischke EdD
Wake Forest School of Medicine
Why?
Amresh D. Hanchate PhD
Wake Forest School of Medicine
Why?
Sally A. Shumaker PhD
Wake Forest School of Medicine
Why?
Kristie Foley PhD, MS
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 1
Next
Prev
Search Criteria
Budgets
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions